Stay updated on Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    A new revision tag v3.5.4 was added to the page’s revision history, replacing v3.5.3. This reflects an update to the document’s versioning without altering its substantive content.
    Difference
    0.1%
    Check dated 2026-05-16T00:11:45.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page’s footer shows an updated site/application revision from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-24T06:11:08.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:31:48.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed. This appears to be a minor site maintenance update that does not alter the page content.
    Difference
    0.1%
    Check dated 2026-03-18T21:20:21.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No visible changes to study details, eligibility criteria, or results content.
    Difference
    0.1%
    Check dated 2026-03-11T20:07:18.000Z thumbnail image
  9. Check
    87 days ago
    Change Detected
    Summary
    Footer area now includes labels/links for 'Moffitt Cancer Center Clinical Trials website' and 'H. Lee Moffitt Cancer Center and Research Institute' along with a 'Helpful Links Provided by' note.
    Difference
    0.2%
    Check dated 2026-03-04T15:08:03.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Lenvatinib in Neuroendocrine Tumors Clinical Trial page.